RNAFIX Trademark

Trademark Overview

On Wednesday, February 23, 2022, a trademark application was filed for RNAFIX with the United States Patent and Trademark Office. The USPTO has given the RNAFIX trademark a serial number of 97280487. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Shape Therapeutics Inc.. The RNAFIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic disorders
rnafix

General Information

Serial Number97280487
Word MarkRNAFIX
Filing DateWednesday, February 23, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShape Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameShape Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Saturday, February 26, 2022NEW APPLICATION ENTERED
Tuesday, March 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 9, 2022ASSIGNED TO EXAMINER
Saturday, April 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 10, 2023SOU EXTENSION 1 FILED
Tuesday, January 10, 2023SOU EXTENSION 1 GRANTED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 2 FILED
Thursday, July 6, 2023SOU EXTENSION 2 GRANTED
Thursday, July 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 2, 2024SOU EXTENSION 3 FILED
Tuesday, January 2, 2024SOU EXTENSION 3 GRANTED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

rnafix disorders genetic treatment preparations pharmaceutical